The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 2.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 72,093 shares of the medical device company’s stock after purchasing an additional 1,668 shares during the quarter. Motley Fool Asset Management LLC’s holdings in Cooper Companies were worth $6,628,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in COO. Fulton Bank N.A. increased its stake in shares of Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after acquiring an additional 109 shares during the last quarter. Torray Investment Partners LLC increased its position in Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after purchasing an additional 132 shares during the last quarter. Mather Group LLC. raised its stake in Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after purchasing an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB boosted its holdings in Cooper Companies by 15.6% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares during the last quarter. Finally, Greenleaf Trust grew its stake in shares of Cooper Companies by 5.0% in the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after buying an additional 139 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.0 %

Shares of COO opened at $81.23 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $16.24 billion, a PE ratio of 41.66, a P/E/G ratio of 2.25 and a beta of 1.02. The company’s 50-day simple moving average is $88.59 and its 200-day simple moving average is $96.72. The Cooper Companies, Inc. has a 1 year low of $77.05 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of several analyst reports. Robert W. Baird reduced their price target on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Citigroup reduced their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Finally, Morgan Stanley lowered their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.